Phase 1 trial study of ¹³¹I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphomaRIZZIERI, David A; AKABANI, Gamal; PEGRAM, Charles N et al.Blood. 2004, Vol 104, Num 3, pp 642-648, issn 0006-4971, 7 p.Article

Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphomaRIZZIERI, David A; SAND, Gregory J; FOSTER, Tracy et al.Cancer. 2004, Vol 100, Num 11, pp 2408-2414, issn 0008-543X, 7 p.Article